A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Adherence Audiences

With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.

Download

DTC Audiences

Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%

A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.

Download

Products

Television

Swoop TV Marketing Overview

Go Omniglass with Swoop’s TV marketing solutions. Bridge audience fragmentation and maximize your TV strategy across leading channel partners with our omniglass offering.

Download

Swoop Agents

Swoop Agents Overview

Unlock your brand.com first-party data potential. Swoop’s award winning chatbot transforms site level engagement into valuable first-party data with conversational AI.

Download

About Swoop

Swoop

Fierce Pharma 2025: Why a Unified Audience is Your Key to 2026 Success

Patient-first impact: building trust and delivering results

Learn More

DTC Marketing

83% of Chronic Condition Patients Surveyed Find Pharma Ads Beneficial

Patient Perspectives on Pharmaceutical Advertising: Exclusive Insights from Swoop

Learn More

Insights

MyHealthTeam

Empowering Patients: How Pharma Ads Drive Better Health Outcomes

Survey reveals 67% of patients with chronic conditions took an action after seeing treatment advertising

Download

Swoop Agents

From Whispers to Wisdom: AI’s Role in Demystifying IUD Conversations

How Swoop Agents provide patients and providers round-the-clock, accurate information.

Download

Back

Television

How AI and RWD Are Redefining TV Advertising for Pharma Marketers

By: [email protected], Content Manager, Swoop

[email protected], Senior Vice President of Business Development for Swoop, spoke with Marc Iskowitz, editor-at-large of MM+M to discuss how custom audiences are transforming TV advertising for the life sciences industry. Pharmaceutical advertising’s traditional reliance on demographic data to inform television media strategy leads to wasteful spend on an overexposed audience and an unoptimized marketing mix. By utilizing brand-exclusive audiences built using AI and real world data that are higher in audience quality, healthcare marketers can optimize their TV advertising reach and frequency for improved engagement and increased script lift.

About the Author

[email protected]

Content Manager

Emilie has nearly a decade of experience in marketing, writing, research and strategy for the pharmaceutical industry. She has contributed to top pharmaceutical publications including American Pharmaceutical Review, European Pharmaceutical Review, Pharmaceutical Manufacturing, Manufacturing Chemist, Pharmaceutical Outsourcing, Specialty Chemicals, and Contract Pharma. Prior to joining Swoop/IPM.ai, Emilie served as Strategic Content Manager and Managing Editor for Pharma’s Almanac where she lent her voice to some of the industry’s top players including GSK, MilliporeSigma and ThermoFisher Scientific.

Swoop
Transforming Omnichannel

Swoop is a market leader in privacy-safe, award-winning omnichannel healthcare marketing solutions. Our platform connects patients, HCPs, and brands at scale across all channels, delivering unmatched engagement and proximity to patients throughout their health journey. By combining AI-driven technology with real-world data (RWD), first- and zero-party data, and engagement data, Swoop empowers pharma marketers to make faster, more precise decisions that improve patient outcomes.